Thermogenesis Holdings Inc
F:THR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CONSOL Energy Inc
NYSE:CNR
|
US |
|
Woodbois Ltd
LSE:WBI
|
GG |
|
G
|
Guangdong Anda Automation Solutions Co Ltd
SSE:688125
|
CN |
|
B
|
BTQ Technologies Corp
NEO:BTQ
|
CA |
|
Y
|
YIT Oyj
OMXH:YIT
|
FI |
|
H
|
Hongbaoli Group Corporation Ltd
SZSE:002165
|
CN |
|
I
|
ITM Power PLC
XBER:IJ8
|
UK |
Thermogenesis Holdings Inc
Total Equity
Thermogenesis Holdings Inc
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Thermogenesis Holdings Inc
F:THR
|
Total Equity
$975k
|
CAGR 3-Years
-55%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-31%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Equity
$24.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
14%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Total Equity
$10.3B
|
CAGR 3-Years
21%
|
CAGR 5-Years
18%
|
CAGR 10-Years
15%
|
|
|
Stryker Corp
NYSE:SYK
|
Total Equity
$22.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
10%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Total Equity
$52.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Equity
$17.8B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
Thermogenesis Holdings Inc
Glance View
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. The company is headquartered in Rancho Cordova, California and currently employs 39 full-time employees. The firm provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for large scale cell manufacturing services. The company manufactures and markets three categories of products, Clinical Bio-Banking Applications, Point-of-Care Applications, and Large Scale Cell Processing and Biomanufacturing. Its Clinical Bio-Banking Applications includes AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Point-of-Care Applications includes PXP Point-of-Care System, PXP-LAVARE System and PXP-1000 System. Its Large Scale Cell Processing and Biomanufacturing includes X-Series Products for general laboratory useand CAR-TXpress Platform for clinical manufacturing.
See Also
What is Thermogenesis Holdings Inc's Total Equity?
Total Equity
975k
USD
Based on the financial report for Mar 31, 2024, Thermogenesis Holdings Inc's Total Equity amounts to 975k USD.
What is Thermogenesis Holdings Inc's Total Equity growth rate?
Total Equity CAGR 10Y
-31%
Over the last year, the Total Equity growth was -84%. The average annual Total Equity growth rates for Thermogenesis Holdings Inc have been -55% over the past three years , -29% over the past five years , and -31% over the past ten years .
